Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-21 14:02 (464 d 21:10 ago) – Posting: # 20853
Views: 3,087

Сomprehensive article:


Over the past 10 years some new fixed combinations containing previously registered drugs were approved for use in the Russian Federation based on the results of a single clinical study of bioequivalence in healthy volunteers versus registered monocomponent reference drug. However, this practice does not fully comply with current Russian legislation.

A. V. Dobrovolskiy - Scientific Centre for Expert Evaluation of Medicinal Products ("FGBU")

Complete thread:

 Admin contact
21,357 posts in 4,459 threads, 1,492 registered users;
online 15 (0 registered, 15 guests [including 3 identified bots]).
Forum time: Sunday 11:12 CET (Europe/Vienna)

Facts are the air of scientists.
Without them you can never fly.    Linus Pauling

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz